BEX1
Protein BEX1
Also known as: BEX1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HBH7
- Gene
- BEX1
- Ensembl
- ENSG00000133169
- Chromosome
- X
- Canonical length
- 125 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
Enables RNA polymerase II-specific DNA-binding transcription factor binding activity. Involved in positive regulation of DNA-binding transcription factor activity and positive regulation of transcription by RNA polymerase II. Part of transcription regulator complex. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
125 residues, UniProt reviewed canonical sequence.
>Q9HBH7|BEX1
1 MESKEKRAVN SLSMENANQE NEEKEQVANK GEPLALPLDA GEYCVPRGNR RRFRVRQPIL
61 QYRWDMMHRL GEPQARMREE NMERIGEEVR QLMEKLREKQ LSHSLRAVST DPPHHDHHDE
121 FCLMPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BEX1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.62
- Highest tissue expression
- 603 nTPM
Expression across tissuesHPA
Tissue
- hypothalamus: 603 nTPM
- cerebral cortex: 537 nTPM
- amygdala: 471 nTPM
- basal ganglia: 461 nTPM
- pituitary gland: 418 nTPM
- hippocampal formation: 370 nTPM
Single-cell type
- granulosa cells: 733 nCPM
- pancreatic islet cells: 533 nCPM
- müller glia: 446 nCPM
- sertoli cells: 259 nCPM
- other brain neurons: 257 nCPM
- retinal horizontal cells: 240 nCPM
Immune cell
- eosinophil: 3.4 nTPM
- naive CD4 T-cell: 1.4 nTPM
- naive B-cell: 1 nTPM
- memory CD4 T-cell: 0.9 nTPM
- NK-cell: 0.9 nTPM
- total PBMC: 0.7 nTPM
Brain region
- hypothalamus: 644 nTPM
- cerebral cortex: 305 nTPM
- pons: 268 nTPM
- basal ganglia: 256 nTPM
- midbrain: 239 nTPM
- hippocampal formation: 205 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.22
- gnomAD pLI
- 0.54
- gnomAD missense Z
- 0.37
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- negative regulation of protein ubiquitination
- nervous system development
- positive regulation of transcription by RNA polymerase II
- signal transduction
Molecular functions
- metal ion binding
- molecular function inhibitor activity
- signaling adaptor activity
- signaling receptor binding
- transcription coactivator binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BEX1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BEX1 as an antibody target. Whether an autoantibody or antibody against BEX1 could matter depends on whether native BEX1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BEX1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BEX1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...